Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |